| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.088 | 0.6 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |